Details for New Drug Application (NDA): 060475
✉ Email this page to a colleague
NDA 060475 describes NEOBIOTIC, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the NEOBIOTIC profile page.
The generic ingredient in NEOBIOTIC is neomycin sulfate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
The generic ingredient in NEOBIOTIC is neomycin sulfate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
Summary for 060475
| Tradename: | NEOBIOTIC |
| Applicant: | Pfizer |
| Ingredient: | neomycin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060475
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 350MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
